18 and older, any sex, with Recovery Following Cholecystectomy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Readiness for DischargePrimary· 2 hours following surgery
Number (percentage) of Participants with Readiness for Discharge (achieving discharge-readiness status at end of 2- hours post-surgery evaluated using the SPEEDs criteria: oxygen saturation, pain control, emesis control, extremity movement, dialogue, and stable vital signs.
Group
Value
95% CI
Normal Saline
26
Acetaminophen
33
Post Operative Pain ScoresSecondary· Every 15 min for 2 hours or until achieving discharge-readiness, whatever comes first, an average of 1 hour
Pain scores every 15 min for 2 hours or until achieving discharge-readiness, whatever comes first, an average of 1 hour.
Visual Analogue Scale (VAS) for pain was used: score on a scale from 0 (no pain) to 10 (worst pain) were recorded.
15 minutes
Group
Value
95% CI
Normal Saline
9
7 – 10
Acetaminophen
7
5 – 9
30 minutes
Group
Value
95% CI
Normal Saline
8
6 – 10
Acetaminophen
7
6 – 8
45 minutes
Group
Value
95% CI
Normal Saline
7
5 – 8
Acetaminophen
6
4 – 8
60 minutes
Group
Value
95% CI
Normal Saline
5
3 – 7
Acetaminophen
4
2 – 6
75 minutes
Group
Value
95% CI
Normal Saline
5
4 – 7
Acetaminophen
4
3 – 6
90 minutes
Group
Value
95% CI
Normal Saline
5
3 – 6
Acetaminophen
3
3 – 6
105 minutes
Group
Value
95% CI
Normal Saline
5
3 – 7
Acetaminophen
3
2 – 8
120 minutes
Group
Value
95% CI
Normal Saline
6.5
5 – 7
Acetaminophen
3
2 – 7
Plasma Stress MarkersSecondary· Before administration of any drug (after placement of intravenous (IV) line), before surgical incision (in operating room (OR)), and 1 h after arrival in post-anesthesia care unit (PACU)
Concentration of the plasma stress markers including epinephrine, norepinephrine, cortisol, interleukins (IL) 6, 8 and 10.
Epinephrine After IV
Group
Value
95% CI
Normal Saline
48
34 – 91
Acetaminophen
65
42 – 87
Epinephrine In OR
Group
Value
95% CI
Normal Saline
42
24 – 52
Acetaminophen
58
37 – 108
Epinephrine 1h in PACU
Group
Value
95% CI
Normal Saline
152
81 – 255
Acetaminophen
128
82 – 184
Norepinephrine After IV
Group
Value
95% CI
Normal Saline
643
546 – 928
Acetaminophen
644
402 – 900
Norepinephrine In OR
Group
Value
95% CI
Normal Saline
532
350 – 665
Acetaminophen
547
341 – 872
Norepinephrine 1h in PACU
Group
Value
95% CI
Normal Saline
689
444 – 1054
Acetaminophen
884
533 – 1121
Cortisol After IV
Group
Value
95% CI
Normal Saline
50.5
30.2 – 76.8
Acetaminophen
54.6
29.9 – 75.8
Cortisol in OR
Group
Value
95% CI
Normal Saline
45.6
28.5 – 74.4
Acetaminophen
49
27.6 – 82.5
The Level of C-reactive ProteinSecondary· Before administration of any drug (after placement of intravenous (IV) line), before surgical incision (in operating room (OR)), and 1 h after arrival in post-anesthesia care unit (PACU)
Concentration of the plasma C-reactive protein (CRP)
CRP after IV
Group
Value
95% CI
Normal Saline
1062.6
510.1 – 3741.4
Acetaminophen
1710.9
714.2 – 3536
CRP in OR
Group
Value
95% CI
Normal Saline
893.4
370.3 – 2336.4
Acetaminophen
1410.7
662.8 – 2943.2
CRP 1h in PACU
Group
Value
95% CI
Normal Saline
746.6
309 – 3861
Acetaminophen
1090.1
449.2 – 3461.5
Time to Rescue Pain MedicationSecondary· From arrival in PACU to the first dose of pain medication is given during 2 hours or until achieving discharge-readiness, whatever comes first, an average of 1 hour.
Time to the first dose of pain medication
Group
Value
95% CI
Normal Saline
19
15 – 28
Acetaminophen
23
17 – 30
Total Dosage of Post Operative OpioidsSecondary· From arrival in PACU for 2 hours or until achieving discharge-readiness, whatever comes first, an average of 1 hour.
Total dosage of post operative opioids (hydromorphone)
Group
Value
95% CI
Normal Saline
1.2
1 – 1.6
Acetaminophen
1
0.6 – 1.6
Patient Satisfaction SurveySecondary· For patients going home the day of surgery the survey is given prior to departing the hospital (approx 5 hours post surgery). For those being admitted, the survey is given once discharge criteria are met in the PACU (approx 3 hours post surgery).
Survey asking patients about their satisfaction with the experience, pain control, and anesthetic rated on a 5 point Likert scale, with 1 being dissatisfied/unlikely and 5 being most satisfied/very likely. Subscales were summed to receive total score.
Group
Value
95% CI
Normal Saline
4
3 – 4
Acetaminophen
4
3 – 4
Number of Participants With Post Operative Nausea and VomitingSecondary· From arrival in PACU for 2 hours or until achieving discharge-readiness, whatever comes first, an average of 1 hour
Number of Participants with Post Operative Nausea and Vomiting
Group
Value
95% CI
Normal Saline
9
Acetaminophen
10
Number of Participants Requiring Additional Anti-emeticsSecondary· From arrival in PACU for 2 hours or until achieving discharge-readiness, whatever comes first, an average of 1 hour
Number of Participants Requiring Additional Anti-emetics (anti-vomiting)
Group
Value
95% CI
Normal Saline
8
Acetaminophen
7
Adverse events — posted to ClinicalTrials.gov
Time frame: From the time patient sign Informed Consent Form for 24 hours or until discharge from the hospital, whatever comes first, an average of 12 hours.
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Study Objective The aim of the proposed study is to examine the effect of Q4 hour multidose IV acetaminophen on patients' readiness for discharge. In doing so the investigators will also investigate the various factors that could potentially contribute to a patient's readiness for discharge such as overall opioid consumption, time to rescue medication, incidence of postoperative nausea and vomiting, pain scores, and perioperative stress markers and their overall correlation with IV acetaminophen intake.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
NCT07502001 — Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
· Phase 1
· not yet recruiting
NCT07525791 — A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not A
· Phase 1
· not yet recruiting
NCT07508241 — A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in
· Phase 1
· not yet recruiting
NCT06994442 — Optimizing Pain Treatment in Children On Mechanical Ventilation
· Phase 3
· recruiting
NCT07101445 — Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injecti
· Phase 4
· recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD)
· NA
· not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis
· NA
· not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
· Phase 2
· not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques
· NA
· not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 9 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02832687.